Related Experiment Videos
Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system
1Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN 55905, USA.
Insights
The new scoring system for autoimmune hepatitis (AIH) rarely identifies overlap with primary sclerosing cholangitis (PSC). This updated system offers better discrimination for diagnosing AIH in PSC patients.
Area of Science:
- Hepatology
- Gastroenterology
- Immunology
Background:
- The International AIH Group recently updated the diagnostic scoring system for autoimmune hepatitis (AIH).
- Primary sclerosing cholangitis (PSC) is a chronic liver disease with potential overlap syndromes.
- Accurate diagnosis of overlapping conditions is crucial for appropriate patient management.
Purpose of the Study:
- To evaluate the prevalence of AIH in patients with primary sclerosing cholangitis (PSC) using the revised international scoring system.
- To assess the utility of the new scoring system in differentiating PSC patients with and without AIH.
- To compare the diagnostic performance of the new scoring system with the previous one.
Main Methods:
- A cohort of 211 patients with cholangiographically proven PSC was retrospectively analyzed.
- The revised international scoring system for AIH was applied to all patients.
- Serum autoantibody titers, immunoglobulin levels, and liver histology were assessed.
Main Results:
- Using the new scoring system, 1.4% of PSC patients met criteria for 'definite' AIH and 6% for 'probable' AIH.
- AIH was excluded in 93% of PSC patients based on the new scoring system.
- Serum IgG, total globulins, autoantibody titers, and histologic scores were key differentiators between PSC with and without AIH.
Conclusions:
- The overlap between PSC and AIH is infrequent.
- The new scoring system appears to improve the precision in identifying potential overlap syndrome between PSC and AIH.
- Further refinements to the scoring system may enhance its discriminatory power for these conditions.
Background/Aim:
Recently, the scoring system for the diagnosis of autoimmune hepatitis (AIH) was modified by the International AIH Group. Our aim was to determine the prevalence of AIH in patients with cholangiographically proven primary sclerosing cholangitis (PSC) using this new scoring system.
Methods:
A total of 211 PSC patients were evaluated.
Results:
Three (1.4%) patients scored more than 15 points ('definite' AIH); 13 (6%) patients scored between 10 and 15 points ('probable' AIH); the remaining 195 (93%) patients had less than 10 points, allowing the exclusion of AIH. The separation of patients with PSC plus AIH from patients with PSC alone was based mostly on serum levels of total globulins (p=0.01), IgG (p=0.001), titers of autoantibodies (p<0.001) and histologic score (p<0.001). Using the older scoring system, four (2%) patients met the criteria for the diagnosis of PSC plus 'definite' AIH and 40 (19%) the diagnosis of PSC plus 'probable' AIH.
Conclusions:
Overlap of PSC and AIH occurs rarely. The new scoring system seems to more precisely define the potential overlap syndrome between PSC and AIH, although further modification of the new scoring system may provide even better discrimination among these conditions.